1. Home
  2. EUDA vs LTRN Comparison

EUDA vs LTRN Comparison

Compare EUDA & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EUDA

EUDA Health Holdings Limited

N/A

Current Price

$15.21

Market Cap

48.8M

Sector

Finance

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$4.00

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
LTRN
Founded
2021
2013
Country
Singapore
United States
Employees
123
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.8M
46.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EUDA
LTRN
Price
$15.21
$4.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$55.00
N/A
AVG Volume (30 Days)
2.5K
202.3K
Earning Date
12-19-2023
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
N/A
P/E Ratio
$123.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$1.11
52 Week High
$25.70
$5.74

Technical Indicators

Market Signals
Indicator
EUDA
LTRN
Relative Strength Index (RSI) 45.95 60.02
Support Level $1.20 $3.89
Resistance Level $15.36 $4.20
Average True Range (ATR) 1.01 0.33
MACD -0.32 -0.04
Stochastic Oscillator 21.87 67.70

Price Performance

Historical Comparison
EUDA
LTRN

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: